Cited 346 times in
Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.